Cicalese, M. P. Et Al. 2016. Update on the safety and efficacy of retroviral gene therapy for immunodeficiency due to adenosine deaminase deficiency. BLOOD , vol.128, no.1 , 45-54.

Cicalese, M. P., Ferrua, F., Castagnaro, L., Pajno, R., Barzaghi, F., Giannelli, S., ... Dionisio, F.(2016). Update on the safety and efficacy of retroviral gene therapy for immunodeficiency due to adenosine deaminase deficiency. BLOOD , vol.128, no.1, 45-54.

Cicalese, Maria Et Al. "Update on the safety and efficacy of retroviral gene therapy for immunodeficiency due to adenosine deaminase deficiency," BLOOD , vol.128, no.1, 45-54, 2016

Cicalese, Maria P. Et Al. "Update on the safety and efficacy of retroviral gene therapy for immunodeficiency due to adenosine deaminase deficiency." BLOOD , vol.128, no.1, pp.45-54, 2016

Cicalese, M. P. Et Al. (2016) . "Update on the safety and efficacy of retroviral gene therapy for immunodeficiency due to adenosine deaminase deficiency." BLOOD , vol.128, no.1, pp.45-54.

@article{article, author={Maria Pia Cicalese Et Al. }, title={Update on the safety and efficacy of retroviral gene therapy for immunodeficiency due to adenosine deaminase deficiency}, journal={BLOOD}, year=2016, pages={45-54} }